A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...

Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD" has been ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made another round of trades on Christmas Eve, December 24, sticking ...

Some companies are better positioned for the consumer-purchasing shift than others. Product diversity could help those firms ...

Easing hot flashes, treating rare genetic diseases and a made-in-Canada vaccine among the year’s notable developments ...

For investors looking for asymmetric upside into 2026, these stocks provide durable structural tailwinds with clear ...